ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The company innovates, acquires, and commercializes proprietary-ingredient technologies that address the signs of aging and support overall wellness. Its flagship ingredient, Niagen® (nicotinamide riboside or NR), is a patented and FDA safety-notified form of vitamin B3 clinically proven to boost NAD+ (nicotinamide adenine dinucleotide) levels. ChromaDex's consumer brand, Tru Niagen®, is sold directly to consumers and through select partners worldwide, aiming to improve health and vitality by safely increasing NAD+.
Serves as the central hub for corporate strategy, research and development leadership, global marketing, financial operations, and administration.
Modern office space in a prominent Los Angeles business district, designed to foster collaboration and scientific innovation.
ChromaDex fosters a science-driven, innovative, and collaborative work environment. Employees are often passionate about health, wellness, and contributing to scientific advancements in aging.
The LA headquarters is pivotal for overseeing global operations, managing intellectual property, coordinating clinical research, and driving the growth of the Tru Niagen® brand.
ChromaDex has a significant global presence, primarily through its Tru Niagen® product, which is sold in numerous countries via e-commerce and partnerships with distributors and retailers. Key markets include the United States, Canada, Hong Kong, Singapore, Australia, and parts of Europe. The company also supports global research collaborations and supplies Niagen® as an ingredient to other businesses worldwide.
10900 Wilshire Blvd, Suite 600
Los Angeles
CA
USA
Address: 1050 S. Fordham St., Suite 100, Longmont, CO 80503
Supports the company's B2B ingredient and reference standards segment, leveraging its expertise in analytical chemistry and natural product testing.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Niagen Bioscience' leadership includes:
Niagen Bioscience has been backed by several prominent investors over the years, including:
ChromaDex has seen stability in its key executive leadership roles over the past year, focusing on strategic growth initiatives. No major C-suite hires or departures have been publicly announced in the last 12 months, indicating continuity in its top management.
Discover the tools Niagen Bioscience uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ChromaDex primarily utilizes the email format of the first initial followed by the last name. For example, if an employee's name is Jane Doe, her email address would likely be jdoe@chromadex.com.
f[last]@chromadex.com
Format
rfried@chromadex.com
Example
85%
Success rate
Business Wire • May 8, 2024
ChromaDex announced its financial results for the first quarter ending March 31, 2024. Total net sales were $23.6 million, an increase of 15% from Q1 2023. Tru Niagen® net sales grew 18% to $19.7 million. The company highlighted ongoing growth in e-commerce and progress in global partnerships....more
Business Wire • March 6, 2024
ChromaDex reported its fourth quarter and full-year 2023 financial results. For the full year, total net sales were $83.6 million, a 12% increase from 2022. The company emphasized its strategy for sustainable growth and expansion of its Tru Niagen® brand....more
NutraIngredients-USA • February 1, 2024
ChromaDex launched Tru Niagen® Immune + Coffeeberry®, a new product combining its flagship Niagen® ingredient with coffee fruit extract to support both NAD+ levels and immune health. This marks an expansion of its product line focusing on synergistic ingredient combinations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Niagen Bioscience, are just a search away.